Melatonin has no effect on the growth, morphology or cell cycle of human breast cancer (MCF-7), cervical cancer (HeLa), osteosarcoma (MG-63) or lymphoblastoid (TK6) cells

Cancer Letters

Volumn 122, Issue 1-2, 1998, Pages 17-23

  Panzer, Annie ^a   Lottering, Mona Lisa ^a   Bianchi, Pepita ^b   Glencross, Deborah K ^c   Stark, Jenny H ^b   Seegers, Johanna C ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c South African Institute of Medical Research   (South Africa)

Author keywords

Cancer; Cell culture; Melatonin

Indexed keywords

ACTIN; ANTIMITOTIC AGENT; BETA TUBULIN; CELL DNA; MELATONIN; NUCLEAR PROTEIN;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL CLONE; CELL CYCLE; CELL GROWTH; CELL STRAIN MCF 7; CELL STRUCTURE; CONTROLLED STUDY; DNA CONTENT; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOBLASTOID CELL; OSTEOSARCOMA; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HELA CELLS; HUMANS; MELATONIN; OSTEOSARCOMA; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0032498285     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00360-1     Document Type: Article

References (23)

1. D.E. Blask, Melatonin in oncology, in: H. Yu, R.J. Reiter (Eds.), Melatonin: Biosynthesis, Physiological Effects, and Clinical Applications, CRC Press, New York, 1993, pp. 448-464.
2. Hill S.M., Blask D.E. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48:1988;6121-6126.
3. Shellard S.A., Whelan R.D., Hill B.T. Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumour cell lines in vitro. Br. J. Cancer. 60:1989;288-290.
4. L'Hermite-Baleriaux M., de Launoit Y. Is melatonin really an in vitro inhibitor of human breast cancer cell proliferation? In Vitro Cell Dev. Biol. 28A:1992;583-584.
5. Bartsch H., Bartsch C., Simon W.E., Flehmig B., Ebels I., Lippert T.H. Antitumor activity of the pineal gland: effect of unidentified substances versus the effect of melatonin. Oncology. 49:1992;27-30.
6. Molis T.M., Walters M.R., Hill S.M. Melatonin modulation of estrogen receptor expression in MCF-7 human breast cancer cells. Int. J. Oncol. 3:1993;687-694.
7. Molis T.M., Spriggs L.L., Hill S.M. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol. Endocrinol. 8:1994;1681-1690.
8. Cos S., Blask D.E. Melatonin modulates growth factor activity in MCF-7 human breast cancer cells. J. Pineal Res. 17:1994;25-32.
9. Ubeda A., Trillo M.A., House D.E., Blackman C.F. Melatonin enhances junctional transfer in normal C3H/10T1/2 cells. Cancer Lett. 91:1995;241-245.
10. Benitez-King G., Anton-Tay F. Calmodulin mediates melatonin cytoskeletal effects. Experientia. 49:1993;635-641.
11. Huerto-Delgadillo L., Anton-Tay F., Benitez-King G. Effects of melatonin on microtubule assembly depend on hormone concentration: role of melatonin as a calmodulin antagonist. J. Pineal Res. 17:1994;55-62.
12. Cos S., Blask D.E., Lemus-Wilson A., Hill A.B. Effects of melatonin on the cell cycle kinetics and 'estrogen-rescue' of MCF-7 human breast cancer cells in culture. J. Pineal Res. 10:1991;36-42.
13. Molis T.M., Spriggs L.L., Jupiter Y., Hill S.M. Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer. J. Pineal Res. 18:1995;93-103.
14. Panzer A., Viljoen M. The validity of melatonin as an oncostatic agent. J. Pineal Res. 22:1997;1-19.
15. Cos S., Recio J., Sanchez-Barcelo E.J. Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin. Life Sci. 58:1996;811-816.
16. Crespo D., Fernandez-Viadero C., Verduga R., Ovejero V., Cos S. Interaction between melatonin and estradiol on morphological and morphometric features of MCF-7 human breast cancer cells. J. Pineal Res. 16:1994;215-222.
17. Gillies R.J., Didier N., Denton M. Determination of cell number in monolayer cultures. Anal. Biochem. 159:1986;109-113.
18. Cos S., Sanchez-Barcelo E.J. Differences between pulsatile or continuous exposure to melatonin on MCF-7 human breast cancer cell proliferation. Cancer Lett. 85:1994;105-109.
19. Seegers J.C., Bohmer L.H., Kruger M.C., Lottering M.L., de Kock M. A comparative study of ochratoxin A-induced apoptosis in hamster kidney and HeLa cells. Toxicol. Appl. Pharmacol. 129:1994;1-11.
20. Seegers J.C., Aveling M.L., van Aswegen C.H., Cross M., Koch F., Joubert W.S. The cytotoxic effects of estradiol-17 beta, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. J. Steroid Biochem. 32:1989;797-809.
21. Cos S., Sanchez-Barcelo E.J. Melatonin inhibition of MCF-7 human breast-cancer cells growth: influence of cell proliferation rate. Cancer Lett. 93:1995;207-212.
22. Cos S., Blask D.E. Effects of the pineal hormone melatonin on the anchorage-independent growth of human breast cancer cells (MCF-7) in a clonogenic culture system. Cancer Lett. 50:1990;115-119.
23. D.E. Blask, S.T. Wilson, Melatonin action on human breast cancer cells: involvement of glutathione metabolism and the redox environment, in: F. Fraschini, R.J. Reiter, B. Stankov (Eds.), The Pineal Gland and Its Hormones: Fundamentals and Clinical Perspectives, Plenum Press, New York, 1995, pp. 209-217.